MEDIUM confidence: 100% data completeness, but the composite (51) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-10-25.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $293M— | $390M+33.4% | $588M+50.6% |
| EPS (dil.) | $-1.39— | $-0.15n/m | $-5.19n/m |
| Free Cash Flow | -$69M— | $45Mn/m | $171M+277.5% |
| Gross Margin | 66.3% | 77.0%+10.7pp | 79.8%+2.8pp |
| Operating Margin | -44.6% | -8.2%+36.4pp | -92.9%-84.8pp |
| Net Margin | -36.9% | -3.1%+33.9pp | -89.9%-86.8pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 23.7%/yr (revenue basis).
Base free cash flow $49M (avg FY2023–FY2025; latest year $171M) · equity value $9.2B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net insider -$113.2M over 180 days (0 open-market buys, 54 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Avg target $110 (last qtr, 11 analysts) → $127 (last mo, 3) (+14.9%).
Buy-rated share 94% → 94% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $0.61 | $0.59 | -4.1% |
| May 2026 | $0.39 | $0.45 | +15.4% |
| Feb 2026 | $0.04 | $0.49 | +1125.0% |
| Nov 2025 | $0.24 | $0.34 | +41.7% |
| Aug 2025 | $0.09 | $0.67 | +644.4% |
| May 2025 | $0.09 | $0.21 | +147.0% |
| Mar 2025 | — | $0.35 | — |
The QScore of 51 for HNGE indicates a neutral outlook, with the stock's short-term score exceeding its long-term score by 12 points. HNGE scores high on momentum, driven by a 128% return over the past year and a bullish 50-day versus 200-day moving average trend. However, the stock trades at a premium, with a P/E of 84.3 and P/B of 26.0, which weighs down its value score. Its growth score is also mixed, with strong revenue growth of 50.6% offset by a significant decline in EPS.